Etiology and management of seborrheic dermatitis

被引：87
作者：
Gupta, AK
Madzia, SE
Batra, R
机构：
[1] Sunnybrook & Womens Coll Hlth Sci Ctr, Dept Med, Div Dermatol, Toronto, ON, Canada
[2] Univ Toronto, Toronto, ON, Canada
[3] Mediprobe Labs Inc, London, ON, Canada
来源：
DERMATOLOGY | 2004年 / 208卷 / 02期
关键词：
seborrheic dermatitis; Malassezia species; antifungals;
D O I：
10.1159/000076478
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
Seborrheic dermatitis (SD) is a common dermatological disorder that varies greatly in severity between individuals and with time. The etiology of this disease is poorly understood. Early investigators focused on the role of Malassezia (previously Pityrosporum) yeasts in the development of SD. Some researchers have hypothesized that there is an immunological component to SD and that this disease is caused by an altered immune response to Malassezia yeasts. However, other researchers view this condition as the result of hyperproliferation. Both antifungal and anti-inflammatory preparations have been used to treat SD effectively and safely. The wide range of antifungal formulations available ( creams, shampoos, oral drugs) provides safe, effective and flexible treatment options for SD. Copyright (C) 2004 S. Karger AG, Basel.
引用
收藏
页码：89 / 93
页数：5
相关论文
共 66 条
[1]   CICLOPIROX OLAMINE - A HYDROXYPYRIDONE ANTIFUNGAL AGENT [J].
ABRAMS, BB ;
HANEL, H ;
HOEHLER, T .
CLINICS IN DERMATOLOGY, 1991, 9 (04) :471-477
[2]   Malassezia furfur invasiveness in a keratinocyte cell line (HaCat):: effects on cytoskeleton and on adhesion molecule and cytokine expression [J].
Baroni, A ;
Perfetto, B ;
Paoletti, I ;
Ruocco, E ;
Canozo, N ;
Orlando, M ;
Buommino, E .
ARCHIVES OF DERMATOLOGICAL RESEARCH, 2001, 293 (08) :414-419
[3]  
Bergbrant IM, 1999, CLIN EXP DERMATOL, V24, P402, DOI 10.1046/j.1365-2230.1999.00512.x
[4]   ADHERENCE OF MALASSEZIA-FURFUR TO HUMAN STRATUM-CORNEUM CELLS IN-VITRO - A STUDY OF HEALTHY-INDIVIDUALS AND PATIENTS WITH SEBORRHEIC DERMATITIS [J].
BERGBRANT, IM ;
FAERGEMANN, J .
MYCOSES, 1994, 37 (5-6) :217-219
[5]  
BERGBRANT IM, 1989, ACTA DERM-VENEREOL, V69, P332
[6]   SEBORRHEIC DERMATITIS IN NEUROLEPTIC-INDUCED PARKINSONISM [J].
BINDER, RL ;
JONELIS, FJ .
ARCHIVES OF DERMATOLOGY, 1983, 119 (06) :473-475
[7]   Tacrolimus 0•1% ointment for seborrhoeic dermatitis:: an open-label pilot study [J].
Braza, TJ ;
DiCarlo, JB ;
Soon, SL ;
McCall, CO .
BRITISH JOURNAL OF DERMATOLOGY, 2003, 148 (06) :1242-1244
[8]  
Caputo R, 2002, G ITAL DERMATOL VENE, V137, P1
[9]   Randomized, open-labeled, non-inferiority study between ciclopiroxolamine 1% cream and ketoconazole 2% foaming gel in mild to moderate facial seborrheic dermatitis [J].
Chosidow, O ;
Maurette, C ;
Dupuy, P .
DERMATOLOGY, 2003, 206 (03) :233-240
[10]  
Crutchfield CE, 2002, CUTIS, V70, P207
1234567